5-hydroxytryptophan has been researched along with Carcinoma, Small Cell in 2 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McMahon, JB | 1 |
| Schuller, HM | 1 |
| Gazdar, AF | 1 |
| Becker, KL | 1 |
| Matsui, K | 1 |
| Fukuoka, M | 1 |
| Takada, M | 1 |
| Kusunoki, Y | 1 |
| Yana, T | 1 |
| Tamura, K | 1 |
| Yoshida, T | 1 |
| Iida, K | 1 |
| Hirashima, T | 1 |
| Tsukada, H | 1 |
| Ushijima, S | 1 |
| Miyawaki, H | 1 |
| Masuda, N | 1 |
1 trial available for 5-hydroxytryptophan and Carcinoma, Small Cell
| Article | Year |
|---|---|
Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Carcinom | 1996 |
1 other study available for 5-hydroxytryptophan and Carcinoma, Small Cell
| Article | Year |
|---|---|
Influence of priming with 5-hydroxytryptophan on APUD characteristics in human small cell lung cancer cell lines.
Topics: 5-Hydroxytryptophan; APUD Cells; Carcinoma, Small Cell; Cell Line; Humans; Lung Neoplasms | 1984 |